Adiponectin and highly sensitive C-reactive protein levels in obese children aged 9 to 15 years

Main Article Content

Frecilia Regina
Kristellina Tirtamulia
Sarah Maria Warouw


Background Childhood obesity is a widespread and growing problem associated with health problems such as metabolic syndrome, diabetes mellitus and cardiovascular disease. A low􀁗grade chronic inflammatory state, reflected by decreased adiponectin and increased highly sensitive C􀁗reactive  protein (hsCRP) levels, may play a role in metabolic syndrome associated with obesity.

Objective To assess and compare adiponectin and hsCRP levels in obese and nonnal weight children.

Methods We conducted a cross-sectional, case􀁗controlled study in Manado from May to July 2010. Subjects were selected from obese, but otherwise healthy children aged 9-15 years. Control subjects were schoolmates 'With normal body mass index (BMI). We perfonned physical examinations, measured blood pressure, weight and height, and calculated BMI for all subjects. After an overnight fast, all subjects were tested for fasting blood glucose, adiponectin and hsCRP levels.

Results The mean adiponectin level in the obese group was 3.6 μg/mL (SD 1.43), lower than that of the normoweight group, 4.8 μg/mL (SD 1.67) (P<0.0001). The mean hsCRP level in the obese group was 3.3 mg/L (SD 3.62) while that of the normoweight group was 0.8 mg/L (SD 1.39) (P<0.0001). There was no inverse correlation between adiponectin and hsCRP levels in obese group (r= 0.048; P= 0.362).

Conclusions Lower adiponectin and higher hsCRP levels in the obese group is consistent 'With a low-grade chronic inflammatory state. Other factors that influence adiponecrin and hsCRP production or inflammatory pathways of other adipokines need further evaluation. Early intervention is needed to reduce body weight in obese children.

Article Details

How to Cite
Regina F, Tirtamulia K, Warouw S. Adiponectin and highly sensitive C-reactive protein levels in obese children aged 9 to 15 years. PI [Internet]. 28Feb.2011 [cited 8Jul.2020];51(1):7-1. Available from:
Received 2016-10-17
Accepted 2016-10-17
Published 2011-02-28


1. Wang Y, Monteiro C, Popkin BM. Trends of obesity and underweight in older children and adolescents in the United States, Brazil, China and Russia. Am J Clin Nutr. 2001;75,911-7.
2. Redinger RN. T he pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol. 2007;3:856-63.
3. Trujillo ME, Scherer PE. Adipose tissue􀁌derived factors: impact on health and disease. Endocr Rev. 2006;27:762- 78.
4. Stern N, Osher E, Greenman Y. Hypoadiponectinemia as a marker of adipocyte dysfunction part I: the biology of adiponectin. J Cardiometab Syndr. 2007;2:174-82.
5. Valle M, Martos R, Gasc6n F, Cafiete R, Zafra MA, Morales R. Low􀁌grade systemic inflammation, hypoadinopectinemia and a high concentration of leptin are present in very young obese children, and correlate Mth metabolic syndrome. Diabetes Metab. 2005;31:55-62.
6. Weiss R, Dziura J, Burgert TS, Tamborlane Wv, Taksali SE, Yeckel Cw, et al. Obesity and the Metabolic Syndrome in Children and Adolescents. N Engl j Med. 2004;350,2362-74.
7. Abraham j, Campbell CY, Cheema A, Gluckman Tj, Blumenthal RS. C-reactive protein in cardiovascular risk assessment: a review of the evidence. J Cardiometab Syndr. 2007;2;119-23.
8. Wu DM, Chu NF, Shen MH, Wang SC. Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan. Clin Biochem. 2006;39;810-5.
9. Kapiotis S, Holzer G, Schaller G, Haumer M, Widhalm H, Weghuber D, et al. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular change. Arterioscler T hromb Vasc Bio!. 2006;26;2541-6.
10. Winer JC, Zern TL, Taksali SE, Dziura J, Cali AMG, Wollschlager M, et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab. 2006;91:4415-23.
11. Mexitalia M. Nutrisi pencegahan: prudent diet. In: Gunawan G, editor. Tumbuh kembang, nutrisi dan endokrin. 5th Continuing Professional Development; Banjannasin 2006 Februari 18􀁛19. Banjarmasin: Indonesian Pediatric Society 􀁛 South Borneo Branch; 2006: p. 29A2.
12. Nagel G, Rapp K, Wabitsch M, Bilchele G, Kroke A, Zollner I, et al. Prevalence and cluster of cardiometabolic biomarkers in overweight and obese schoolchildren: results from a large survey in southwest Germany. Clin Chem. 2008;54:317-25.
13. Ohashi K, Ouchi N, Kihara S. Adiponectin I164T mutation is associated 'With the metabolic syndrome and coronary artery disease. J Am Coli Cardio!. 2004;43; 1195-1200.
14. Stumvoll M, Tschritter 0, Fritsche A. Association of the T􀁛G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction 'With family history of type 2 diabetes. Diabetes. 2002;51;37-41.
15. Schiel R, Beltschikow W, Kramer G, Stein G. Overweight, obesity and elevated blood pressure in children and adolescents. EurJ Med Res. 2006;11:97-101.
16. Hendarto A. Telaah peran leptin, adiponektin, tumor necrosis factor􀁛a., C reactive protein, asupan karoohidrat dan lemak terhadap resistensi insulin pada anak lelaki superobes usia 5􀁛9 tahun [dissertation]. Jakarta: University of Indonesia, 2009.
17. Punthakee Z, Delvin EE, O'Loughlin J, Paradis G, Levy E, Platt RW, et al. Adiponectin, adiposity, and insulin resistance in children and adolescents. J Clin Endocrinol Metab. 2006;91;2119-25.
18. Araki S, Dobashi K, Kubo K, Asayama K, Shirahata A. High molecular weight, rather than total, adiponectin levels better reflect metabolic abnonnalities associated with childhood obesity. J Clin Endocrinol Metab. 2006;91:5113-6.